The Journal of Immunology, Vol 157, Issue 6 2358-2365, Copyright © 1996 by American Association of Immunologists

ARTICLES

Selective activation of CD8 T cell effector functions by epitope variants of lymphocytic choriomeningitis virus glycoprotein

S Martin, H Kohler, HU Weltzien and C Leipner
Max Planck Institute for Immunobiology, Freiburg, Germany.

We provide evidence for selective activation of different effector functions of CD8+ T lymphocytes by altered peptide ligands. A T cell epitope from the glycoprotein of lymphocytic choriomeningitis virus (p33-41) and single amino acid variants thereof were used for primary in vitro induction of CTL clones. When the CTL were analyzed for cytotoxicity, proliferation, IFN-gamma production, and Ca2+ mobilization, we found that some of the clones showed activation of only their cytotoxic effector function when stimulated with variants of their inducing peptides. For one clone, cytotoxic reactivity was readily detected to the inducing peptide and three of four variants, but only the former was also able to trigger proliferation, IFN-gamma production, and Ca2+ mobilization. Another clone also revealed this dichotomy, but in this case some of the altered peptide ligands in addition to the inducing peptide were able to stimulate the full spectrum of effector functions, whereas others only stimulated cytotoxicity. A third clone revealed inefficient triggering of some effector functions by the peptide variants. Our data suggest that, as described for CD4 T cells, altered peptide ligands may lead to partial activation of effector functions of CD8 T cells. In addition, ligands with glycine substitutions in potential TCR contact positions induced CTL, which were able to recognize peptides with a variety of amino acids in the former glycine position.

This article has been cited by other articles:

				S. Mostbock, S. Vidal, J. Schlom, and H. Sabzevari Enhanced Levels of Costimulation Lead to Reduced Effector/Memory CD8+ T Cell Functionality J. Immunol., September 15, 2007; 179(6): 3524 - 3534. [Abstract] [Full Text] [PDF]

				T. S. Kim and S. Perlman Protection Against CTL Escape and Clinical Disease in a Murine Model of Virus Persistence J. Immunol., August 15, 2003; 171(4): 2006 - 2013. [Abstract] [Full Text] [PDF]

				K. E. de Visser, T. A. Cordaro, H. W. H. G. Kessels, F. H. Tirion, T. N. M. Schumacher, and A. M. Kruisbeek Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide Ligands J. Immunol., October 1, 2001; 167(7): 3818 - 3828. [Abstract] [Full Text] [PDF]

				B. Kessler, D. Hudrisier, M. Schroeter, J. Tschopp, J.-C. Cerottini, and I. F. Luescher Peptide Modification or Blocking of CD8, Resulting in Weak TCR Signaling, Can Activate CTL for Fas- But Not Perforin-Dependent Cytotoxicity or Cytokine Production J. Immunol., December 15, 1998; 161(12): 6939 - 6946. [Abstract] [Full Text] [PDF]

				D. Hudrisier, B. Kessler, S. Valitutti, C. Horvath, J.-C. Cerottini, and I. F. Luescher The Efficiency of Antigen Recognition by CD8+ CTL Clones Is Determined by the Frequency of Serial TCR Engagement J. Immunol., July 15, 1998; 161(2): 553 - 562. [Abstract] [Full Text] [PDF]

				B. Kessler, D. Hudrisier, J.-C. Cerottini, and I. F. Luescher Role of CD8 in Aberrant Function of Cytotoxic T Lymphocytes J. Exp. Med., December 15, 1997; 186(12): 2033 - 2038. [Abstract] [Full Text] [PDF]

				D. Hudrisier, J. Riond, O. Burlet-Schiltz, M. G. von Herrath, H. Lewicki, B. Monsarrat, M. B. A. Oldstone, and J. E. Gairin Structural and Functional Identification of Major Histocompatibility Complex Class I-restricted Self-peptides as Naturally Occurring Molecular Mimics of Viral Antigens. POSSIBLE ROLE IN CD8+ T CELL-MEDIATED, VIRUS-INDUCED AUTOIMMUNE DISEASE J. Biol. Chem., May 25, 2001; 276(22): 19396 - 19403. [Abstract] [Full Text] [PDF]